Advertisement
Canada markets open in 2 hours 26 minutes
  • S&P/TSX

    22,259.16
    -31.46 (-0.14%)
     
  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     
  • DOW

    39,056.39
    +172.13 (+0.44%)
     
  • CAD/USD

    0.7288
    -0.0000 (-0.01%)
     
  • CRUDE OIL

    79.76
    +0.77 (+0.97%)
     
  • Bitcoin CAD

    83,454.68
    -2,212.17 (-2.58%)
     
  • CMC Crypto 200

    1,318.37
    +18.27 (+1.40%)
     
  • GOLD FUTURES

    2,318.50
    -3.80 (-0.16%)
     
  • RUSSELL 2000

    2,055.14
    -9.51 (-0.46%)
     
  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     
  • NASDAQ futures

    18,138.75
    -47.75 (-0.26%)
     
  • VOLATILITY

    13.25
    +0.25 (+1.92%)
     
  • FTSE

    8,364.07
    +10.02 (+0.12%)
     
  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     
  • CAD/EUR

    0.6786
    +0.0010 (+0.15%)
     

Why Shares of Compugen Rose 16.5% on Wednesday

Why Shares of Compugen Rose 16.5% on Wednesday

Shares of Compugen (NASDAQ: CGEN), a clinical-stage biotech company that specializes in immunology therapies to treat cancer, saw its shares rise 16.5% on Wednesday. The stock closed on Tuesday at $1.03, then opened on Wednesday at $1.01, before jumping to $1.23 in the late afternoon and closing at $1.20. The stock has been volatile, with a 52-week low of $0.51 and a 52-week high of $4.88.